Search results
US Supreme Court to consider reviving key approval for Utah oil railway
Reuters· 2 hours agoThe U.S. Supreme Court on Monday agreed to consider whether to revive a key approval by federal ...
They Came to See Trump. First They Heard a Pitch to Buy Gold and Silver.
New York Times· 2 hours agoAt a recent campaign speech, one of Donald Trump’s warm-up acts was a precious metals salesman being...
A viral blog post from a bureaucrat exposes why tech billionaires fear Biden — and fund Trump
Salon via Yahoo News· 12 hours agoRather than dial back the shady behavior, the tech industry is turning to Donald Trump, a man whose...
Federal regulators approve final rule for AVM usage - HousingWire
HousingWire· 4 days agoOn Thursday, two U.S. regulators — the Office of the Comptroller of the Currency (OCC) and the...
Wall Street Expects ‘Cautious’ Payouts After Bank Stress Tests
Barrons.com· 8 hours agoIf banks’ earnings offer a window into the economy’s health, then the annual results of big lenders’...
Boeing hid questionable parts from regulators that may have been installed in 737 Max planes, new...
CNN Business via Yahoo Finance· 6 days agoA current Boeing employee claims that the company tried to shield broken or out-of-specification 737...
AI Stocks: Tech Giants, Cloud Titans, Chipmakers Battle For An Edge
Investor's Business Daily· 7 hours agoA bellwether for AI stocks, chipmaker Nvidia's shares have jumped 155% in 2024. However, NVDA stock...
Citi's 'living will' flaws manageable but distracting, J.P.Morgan says
Reuters via Yahoo Finance· 8 hours ago"It adds to the list of issues that management needs to focus on," the brokerage said, noting...
Supreme Court won’t take up Georgia dispute over ‘at-large’ elections and minority vote dilution
CNN via AOL· 7 hours agoThe Supreme Court won’t take up a case challenging Georgia’s system for electing its public utility...
ImmunityBio Loses Bid to Dodge Investor Suit Over Drug Rejection
Bloomberg Law· 3 days agoImmunityBio Inc. must face a shareholder lawsuit alleging the biotech company misled investors about the manufacturing process for its flagship drug candidate. The suit was ...